AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lariago 64.5mg Injection

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Chloroquine (64.5mg)

Overview Lariago 64.5mg Injection

Malarex 64.5mg Injection combats malaria parasites, preventing and treating the infection. Its mechanism involves eliminating the malaria-causing organism, halting disease progression. Administration is strictly by a medical professional via injection; self-injection is prohibited. Mosquito bite prevention is crucial: apply insect repellent to exposed skin, spray repellents indoors, and wear light, protective clothing after dusk. Potential side effects include weakness, nausea, vomiting, rash, itching, abdominal discomfort, diarrhea, and appetite loss. Injection site reactions such as pain, swelling, or redness may occur. Persistent side effects warrant medical attention. Diabetics should inform their physician, as this medication can lower blood glucose; regular blood sugar monitoring is advised. Blurred vision may occur, necessitating regular eye exams during treatment. Long-term use may require regular blood cell count monitoring. Report any unexplained bruising, bleeding, sore throat, fever, or fatigue to your doctor immediately.

Primary Ingredients of Lariago 64.5mg Injection

The provided text is "undefined," which lacks meaning and cannot be rephrased. A meaningful text is required for a paraphrase.

Uses of Lariago 64.5mg Injection

Managing Malaria Infections

Major Benefits of Lariago 64.5mg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Lariago 64.5mg Injection:

  • Weakness
  • Rash
  • Headache
  • Dizziness
  • Vomiting
  • Nausea
  • Stomach pain
  • Loss of appetite
  • Diarrhea

How to use Lariago 64.5mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Lariago 64.5mg Injection works:

Malaria is effectively combated by the antiparasitic Lariago 64.5mg Injection. Its mechanism involves elevating blood heme concentrations, a substance lethal to the malaria parasite, thus eliminating the parasite and halting disease progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of combining Lariago 64.5mg Injection with alcohol is undetermined. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Lariago 64.5mg Injection during pregnancy carries potential risks. While human data is scarce, animal research indicates possible harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the 64.5mg Lariago injection are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no apparent infant risk.

DrivingDrivingUNSAFE

Administering Lariago 64.5mg Injection might induce adverse reactions that impair driving capabilities. These reactions can include blurry vision or difficulty focusing, potentially affecting the ability to operate a vehicle safely.

KidneyKidneyCAUTION

Exercise caution when administering the 64.5mg Lariago Injection to individuals with impaired renal function. Dosage modification for Lariago 64.5mg Injection might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Lariago 64.5mg Injection cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Routine liver function assessments may be necessary during treatment.

What if you forget to take Lariago 64.5mg Injection :

NA

Facts to Know About Lariago 64.5mg Injection

LabelValue
Chemical Type 4-Aminoquinoline analog
Developing Habits No.
Treatment Category Ophthalmology
Actions Aminoquinoline Antimalarials

FAQs on Lariago 64.5mg Injection

Lariago 64.5mg Injection treats and prevents malaria.
Malaria symptoms can appear as soon as seven days, or up to 18 days, after an infected mosquito bite. Initial symptoms mimic the flu, including chills, fever, muscle aches, vomiting, headache, and diarrhea.
Prolonged use of Lariago 64.5mg Injection, containing chloroquine, necessitates regular eye exams. This is to monitor for potential side effects such as blurred vision, reading difficulties (including word loss), and the rare but possible development of retinopathy.
Tell your doctor if you have psoriasis before using Lariago 64.5mg Injection, as it could worsen your condition.
This medication may cause common side effects such as stomach pain, nausea, vomiting, and headache. Taking it with food may lessen these effects.
Insufficient medical evidence supports chloroquine's effectiveness against COVID-19. Consequently, using Lariago 64.5mg Injection for COVID-19 treatment without a doctor's consultation is not recommended.
Allow at least four hours between taking an antacid and other medications.
Initially approved to combat malaria, hydroxychloroquine and chloroquine differ significantly in their side effect profiles. Hydroxychloroquine, with its milder side effects, enjoys greater current use. Furthermore, it's approved for rheumatoid arthritis and lupus, unlike chloroquine.
Protect yourself from malaria by covering exposed skin, using mosquito nets and repellent to avoid mosquito bites. Consult your doctor about malaria prevention medication; if prescribed, take the correct antimalarial tablets, at the correct dosage, and complete the entire course.
Lariago 64.5mg Injection treats and prevents malaria.
Malaria symptoms can appear as soon as seven days, or up to 18 days, after an infected mosquito bite. Initial symptoms mimic the flu, including chills, fever, muscle aches, vomiting, headache, and diarrhea.
Prolonged use of Lariago 64.5mg Injection, containing chloroquine, necessitates regular eye examinations. This is to monitor for potential side effects such as blurred vision, reading difficulties (including the appearance of disappearing words), and the rare occurrence of retinopathy.
Tell your doctor if you have psoriasis before using Lariago 64.5mg Injection, as it could worsen your condition.
Stomach pain, nausea, vomiting, and headache are common side effects. Taking this medication with food may lessen these effects.
Insufficient medical evidence supports chloroquine's effectiveness against COVID-19. Consequently, avoid using Lariago 64.5mg Injection for COVID-19 treatment without consulting a physician.
Allow at least four hours between taking an antacid and other medications.
Initially approved for malaria treatment, hydroxychloroquine and chloroquine differ significantly in their side effect profiles. Hydroxychloroquine, exhibiting fewer side effects, is now the more prevalent choice. Furthermore, its therapeutic applications extend to rheumatoid arthritis and lupus, unlike chloroquine.
Protect yourself from malaria by covering exposed skin, using mosquito nets and repellent to avoid mosquito bites. Consult your doctor about malaria prevention medication; if prescribed, take the correct antimalarial tablets, at the correct dosage, and complete the entire course.
Lariago 64.5mg Injection
10
MRP 13
20% off